Skip to main content
. 2018 Jul 27;9:810. doi: 10.3389/fphar.2018.00810

Figure 6.

Figure 6

Forest plot of serum BNP (A) and NT-proBNP (B) of XMLI plus conventional therapy vs. conventional therapy alone for CHF treatment. I2 and P are the criterion for the heterogeneity test, Inline graphic pooled mean difference, —Inline graphic— mean difference and 95% CI. BNP, brain natriuretic peptide; NT-proBNP, N-terminal pro-brain natriuretic peptide; XMLI, Xinmailong injection, CHF, chronic heart failure, CI, confidence interval.